Skip to main content

Table 2 Summary of TEAE and ADR (safety set, n = 3370)

From: Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO)

Variable

TEAE

ADR

Total

902 (26.8) [1727]

332 (9.9) [626]

Serious

163 (4.8) [225]

11 (0.3) [14]

Leading to drug withdrawal

255 (7.6) [307]

185 (5.5) [215]

Leading to death

5 (0.2) [7]

0 [0]

  1. Data are presented as number (%) [case]
  2. TEAE treatment-emergent adverse event, ADR adverse drug reaction
Back to article page

Clinical Hypertension

ISSN: 2056-5909

Contact us